Our Q2 2023 results will be published on August 3, 2023, at 7 a.m. (CEST). Our conference call for the media will take place at 9:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST).
Investors
Welcome to our Investor Relations
Here you’ll find everything you might be interested in if you want to invest in vibrant science and technology.
-
![investors-compass-cutout]()
5 reasons to invest
We develop products and solutions that make life better – and have been successfully doing so for more than 350 years. And when you’ve prospered for centuries as we have, you must have done a few things right.Read More -
![Sustainable Development Goals 800 600 4 3]()
Sustainability
For us, scientific progress and responsible entrepreneurship go hand in hand, enabling us to create a sustainable future for everyoneRead more -
![Generic Graphic]()
Reports & Financials
Merck KGaA, Darmstadt, Germany, keeps growing profitably. The excellent performance of our business shows that we are on the right track. See for yourself in our comprehensive reports and financials.Read More
Upcoming Events
View All Events19 Oct 2023
Capital Markets Day 2023
Our Capital Markets Day 2023 is taking place on Thursday, October 19, 2023.
Investor Related News
View All News-
Press Releases
MilliporeSigma Increases Global Commitment to Biosafety Testing With ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Life Science business sector is investing € 35 mil
2023/05/31
-
Press Releases
Merck KGaA, Darmstadt, Germany, Collaborates with Research Groups Based in ...
Merck KGaA, Darmstadt, Germany announced a three-year collaboration with the research group of John Hartwig at University of California, Berkeley and Lawrence Berkeley National Laboratory, Berkeley, California.
2023/05/31
-
Press Releases
Life Science Business of Merck KGaA, Darmstadt, Germany Study: mRNA Technology ...
According to a recent study sponsored by the Life Science business of Merck KGaA, Darmstadt, Germany, mRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers.
2023/05/31
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price
Capital Market Days
Learn MoreCapital Market Days
At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.
Webcasts & Presentations
Learn MoreWebcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
Annual General Meeting
Learn MoreAnnual General Meeting
Every year, our shareholders come together to make important decisions on our company’s business. We provide comprehensive material to help them make well-informed voting decisions.
RSS Feeds
Open one of the following links in a RSS feeder of your choice:
Get in touch!
We're here to help. Get in touch if you have any questions.
+49 6151 72 3321
+49 6151 72 91 3321